UniQure Reports $3.46 Per Share Loss for 2025
QURE sits 19% above its 52-week low of $7.76 on elevated volume (2.4× avg).
Summary
uniQure N.V. announced a loss of $3.46 per share for the full year 2025. This financial update provides a critical insight into the company's operational performance and profitability, which is a key metric for investors. While the timeline shows recent SEC filings and a class action lawsuit, this specific earnings result is new information. A significant loss per share can negatively impact investor sentiment and put pressure on the stock, especially for a biotechnology company in the development phase. Traders will be closely watching for further details on the drivers of this loss and any forward-looking guidance from management.
At the time of this announcement, QURE was trading at $9.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $962.9M. The 52-week trading range was $7.76 to $71.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.